Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy

BACKGROUND: We have previously shown that HCC patients and healthy subjects are equally responsive to a RNAdjuvant(®), a novel TLR-7/8/RIG-I agonist based on noncoding RNA developed by CureVac, by an ex vivo evaluation. However, the immunological effect of adjuvants on immune cells from cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauriello, Angela, Manolio, Carmen, Cavalluzzo, Beatrice, Avallone, Antonio, Borrelli, Marco, Morabito, Alessandro, Iovine, Emanuele, Chambery, Angela, Russo, Rosita, Tornesello, Maria Lina, Buonaguro, Franco M., Tagliamonte, Maria, Buonaguro, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977281/
https://www.ncbi.nlm.nih.gov/pubmed/31973714
http://dx.doi.org/10.1186/s12967-020-02218-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977281/
https://www.ncbi.nlm.nih.gov/pubmed/31973714
http://dx.doi.org/10.1186/s12967-020-02218-x

Ejemplares similares